MMP1 and oral cavity cancer: Moreover, salivary MMP-1 levels in stages I, II, III, and IV oral cavity cancer patients were higher than those in non-cancerous groups (HC and OPMD), with AUCs of 0.839, 0.908, 0.899, and 0.946, respectively (Figure 4B).